Skip to content

Quantitation of Organophosphate Metabolites in Urine by Lc/Ms/Ms

by Centers for Disease Control and Prevention

De Novo DEN130005

Active United States

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 10 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA De Novo, synced 10 Oct 2026. What this means

Regulatory status

as of registry sync 10 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA De NovoDENG De Novo granted · Post-NSE NumberDEN130005 Date8 Aug 2013DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 10 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

De Novo

De Novo Number
FDA Product Code
PDY
Device Class
Class II
Regulation
21 CFR Part 862.3652
Advisory Committee
Clinical Toxicology
FDA Decision
DENG De Novo granted

Other devices from Centers for Disease Control and Prevention

See all devices from Centers for Disease Control and Prevention →